Primary peritoneal carcinosarcoma (malignant mixed mullerian tumor): Report of a case with five-year disease free survival after surgery and chemoradiation and a review of literature

Acta Oncologica

Volumn 44, Issue 7, 2005, Pages 756-760

  Ko, Ma Lee ^a   Jeng, Cherng Jye ^a,b,c   Huang, Shih Hung ^a   Shen, Jenta ^d   Tzeng, Chii Ruey ^c   Chen, Su Chee ^a  

^a CATHAY GENERAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^d CALIFORNIA PACIFIC MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACARBAZINE; DOXORUBICIN; EPIRUBICIN; IFOSFAMIDE; PIRARUBICIN; VINCRISTINE;

ADULT; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CASE REPORT; FEMALE; HUMAN; MEDICAL LITERATURE; MIXED MULLERIAN TUMOR; PERITONEUM CANCER; PRIORITY JOURNAL; REVIEW; SURVIVAL TIME;

ANTINEOPLASTIC AGENTS; CARCINOSARCOMA; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; LAPAROTOMY; MIDDLE AGED; MIXED TUMOR, MALIGNANT; MIXED TUMOR, MULLERIAN; PERITONEAL NEOPLASMS; RADIOTHERAPY DOSAGE;

EID: 27544441126     PISSN: 0284186X     EISSN: None     Source Type: Journal    
DOI: 10.1080/02841860500252016     Document Type: Review

References (20)

1. Shen DH, Khoo US, Xue WC, Ngan HY, Wang JL, Liu VW, et al. Primary peritoneal malignant mixed mullerian tumors. A clinicopathologic, immunohistochemical and genetic study. Cancer 2001;91:1052-60.
2. Dincer AD, Timmins P, Pietrocola D, Fisher H, Ambros RA. Primary peritoneal mullerian adenosarcoma with sarcomatous overgrowth associated with endometriosis: a case report. Int J Gynecol Patho 2001;21:65-8.
3. Garamvoelgyi E, Guillou L, Gebhard S, Salmeron M, Seematter RJ, Hadji MH. Primary malignant mixed mullerian tumor (metaplastic carcinoma) of the female peritoneum. A clinical, pathologic, and immunohistochemical study of three cases and a review of literature. Cancer 1994;74:854-63.
4. Wei L, Wang J, Zhang X, Cui H, Shen D, Qian H. Primary omental malignant mixed mullerian tumor in a 67-year-old woman. Chin Med J 2002;115:138-40.
5. Garde JR, Jones MA, McAfee R, Tarraza HM. Extragenital malignant mixed mullerian tumor: review of literature. Gynecol Oncol 1991;43:186-90.
6. Parker RL, Dadmanesh F, Young RH, Clement PB. Polypoid endometriosis. A clinicopathologic analysis of 24 cases and a review of the literature. Am J Surg Pathol 2004;28: 285-97.
7. Mira JL, Fenoglio-Preiser CM, Husseinzadeh N. Malignant mixed mullerian tumor of the extraovarian secondary mullerian system. Report of two cases and review of English literature. Arch Pathol Lab Med 1995;119:1044-9.
8. Sumathi VP, Murnaghan M, Dobbs P, McCluggage WG. Extragenital Mullerian carcinosarcoma arising from the peritoneum: report of two cases. Int J Gynecol Cancer 2002;12:164-7.
9. McCluggage WC. Malignant biphasic uterine tumors: carcinosarcomas or metastatic carcinomas? J Clin Pathol 2002; 55:321-5.
10. Shintaku M, Matsumoto T. Primary Mullerian carcinosarcoma of the peritoneum: report of a case. Int J Gynecol Pathol 2001;20:191-5.
11. Chen KT, Wolk RW. Extragenital malignant mixed mullerian tumor. Gynecol Oncol 1988;30:422-6.
12. Rose PG, Rodriguez M, Abdul-Karim FW. Malignant mixed mullerian tumor of the female peritoneum: treatment and outcome of three cases. Gynecol Oncol 1997;65:523-5.
13. Thigpen JT, Blessing JA, Beecham J, Homesley H, Yordan E. Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study. J Clin Oncol 1991;9: 1962-6.
14. Topuz E, Eralp A, Aydiner A, Saip P, Tas F, Yavuz E, et al. The role of chemotherapy in malignant mixed tumors of the female genital tract. Eur J Gynecol Oncol 2001;22:469-72.
15. Inthasorn P, Carter J, Valmadre S, Beale P, Russel P, Dalrymple C. Analysis of clinicopathologic factors in malignant mixed Mullerian tumors of the uterine corpus. Int J Gynecol Cancer 2002;12:348-53.
16. Arrastia C, Fruchter R, Clark M, Maiman M, Remy JC, Macasaet M, et al. Uterine carcinosarcomas. Incidence and trends in management and survival. Gynecol Oncol 1997;65: 158-63.
17. Callister M, Ramondetta LM, Jhingran A, Burke TW, Eifel PJ. Malignant mixed Mullerian tumors of the uterus: Analysis patterns of failure, prognostic factors and treatment outcome. Int J Radiat Oncol Biol Phys 2004;58:786-96.
18. Goshen R, Chu W, Elit L, Pal T, Hakimi J, Ackerman I, et al. Is uterine papillary serous adenocarcinoma a manifestation of the hereditary breast-ovarian cancer syndrome? Gynecol Oncol 2000;79:477-81.
19. Menczer J, Chetrit A, Barda G, Lubin F, Fishier Y, Sltaras M, et al. Frequency of BRCA mutations in primary peritoneal carcinoma in Israeli Jewish women. Gynecol Oncol 2003;88:58-61.
20. Khoo US, Ngan HY, Cheung AN, Chan KY, Lu J, Chan VW, et al. Mutational analysis of BRCA1 and BRCA2 genes in Chinese ovarian cancer identifies 6 novel germline mutations. Hum Mutat 2000;16:88-9.